C-Arms Market Report

To learn more about this report, Download Free Sample Report

Global C-Arms Market Size

As per our report, the size of the global C-arms market was worth USD 3.71 billion in 2025 and is estimated to grow at a CAGR of 3.86% and will reach USD 5.21 billion by 2034. The C-arms market size was valued at USD 3.85 billion in 2026

A C-arm is a mobile medical imaging device that uses X-ray technology to provide real-time moving images during surgical and interventional procedures. These devices are indispensable for real-time visualisation during surgical procedures, orthopaedic interventions, and pain management therapies. According to the World Health Organisation, approximately 234 million major surgical procedures are performed each year globally, creating a substantial baseline demand for intraoperative imaging solutions. As per a survey, 30% of surveyed surgeons utilised intraoperative fluoroscopy in over 50% of their operations, rather than the American College of Radiology tracking an official national surgical baseline metric. These statistics underscore the critical role of C-arms in enhancing surgical accuracy and patient safety across diverse medical specialities. The market is driven by the transition from analogue to digital flat panel detectors, which offer superior image quality and lower radiation doses. Regulatory bodies increasingly mandate strict radiation safety standards, prompting healthcare facilities to upgrade older equipment. Consequently, the industry witnesses continuous innovation in miniaturisation and wireless connectivity to support minimally invasive techniques and improve workflow efficiency in modern operating rooms.

MARKET DRIVERS

Rising Prevalence of Orthopaedic and Trauma Conditions

The escalating prevalence of orthopaedic disorders and trauma cases significantly fuels the growth of the C-arms market. This is due to the necessity for precise intraoperative imaging. According to the Global Burden of Disease Study, musculoskeletal conditions affect approximately 1.71 billion people globally, with conditions like osteoarthritis and fractures being key contributors to global disability and surgical requirements. As per the International Osteoporosis Foundation, worldwide, approximately one in three women and one in five men over the age of 50 will experience an osteoporotic fracture. This demographic trend drives hospitals and ambulatory surgical centres to invest in high-resolution C-arms capable of supporting complex joint replacements and spinal fusions. The ageing global population further amplifies the incidence of degenerative bone diseases requiring frequent surgical corrections. Surgeons rely on real-time imaging to minimise tissue damage and ensure accurate alignment of prosthetics. Consequently, the growing burden of musculoskeletal ailments acts as a primary driver by creating consistent and expanding demand for advanced fluoroscopic equipment in both emergency and elective surgical settings.

Shift Toward Minimally Invasive Surgical Procedures

There is a widespread shift toward minimally invasive surgical procedures, which contributes to the expansion of the C-arms market. This transition boosts the demand for compact, high-performance C-arm systems that facilitate precision in confined anatomical spaces. According to studies, minimally invasive surgery techniques have grown significantly in recent decades across general surgery subspecialties. As per sources, the utilisation of real-time intraoperative fluoroscopic visualisation has risen across general surgical applications to facilitate navigation of complex anatomy. This clinical preference drives manufacturers to develop lightweight mobile C-arms with enhanced manoeuvrability and digital flat panel detectors that provide clear images with minimal radiation exposure. Hospitals prioritise these advanced systems to support outpatient surgeries and same-day discharge protocols, which are becoming standard in value-based care models. The ability of modern C-arms to integrate with navigation systems further enhances their utility in delicate procedures. Thus, the expansion of minimally invasive surgery serves as a robust driver by necessitating specialised imaging tools that align with contemporary surgical best practices.

MARKET RESTRAINTS

High Capital Expenditure and Maintenance Costs

Substantial capital expenditure and ongoing maintenance costs significantly hinder the procurement of advanced systems in the C-arms market. This financial burden is particularly evident in resource-constrained healthcare settings. According to the World Bank, combined government and donor spending on health in 2024 averaged $17 per capita in low-income countries and $47 per capita in lower-middle-income countries, limiting resources for healthcare infrastructure. As per studies, the complete total cost of ownership for top-tier digital flat-panel C-arm systems can represent a multi-hundred-thousand-dollar expenditure over their lifetime, including acquisition, installation, specialised training, and extended preventative maintenance service contracts. These high costs force many institutions to rely on outdated analogue systems or delay upgrades despite clinical benefits. Budget constraints also limit the adoption of supplementary technologies such as 3D imaging capabilities, which require additional investment. The financial burden is exacerbated by the need for specialised shielding and infrastructure modifications to accommodate new installations. Hence, economic limitations restrict market growth by preventing widespread access to state-of-the-art fluoroscopic technology in emerging markets and underfunded healthcare sectors.

Stringent Radiation Safety Regulations and Compliance Burdens

Rigorous radiation safety regulations and compliance burdens impede the rapid deployment of C-arm systems in the global market. Furthermore, these strict requirements limit operational flexibility across various healthcare environments. The International Atomic Energy Agency mandates strict dose limits for both patients and medical staff, requiring regular calibration and monitoring of fluoroscopic equipment to prevent excessive exposure. According to the National Council on Radiation Protection and Measurements, healthcare workers involved in fluoroscopically guided procedures receive higher occupational radiation doses than other medical specialities, necessitating comprehensive safety protocols and protective gear. These regulatory requirements increase operational complexity and costs, as facilities must invest in dosimetry services, staff training, and periodic inspections. Noncompliance can result in severe penalties, license suspensions, or legal liabilities, discouraging some providers from expanding their fluoroscopy services. The need for lead-lined rooms and specialised ventilation further adds to the infrastructure costs. As a result, stringent safety standards act as a restraint by increasing the administrative and financial load on healthcare providers, thereby slowing the adoption of new C-arm technologies in highly regulated jurisdictions.

MARKET OPPORTUNITIES

Integration of Artificial Intelligence and Advanced Imaging Software

The integration of artificial intelligence and advanced imaging software offers a significant opportunity for the C-arms market. Specifically, this technological advancement enhances both diagnostic capabilities and workflow efficiency. According to research, deep learning and artificial intelligence algorithms are being actively evaluated to reduce image noise and minimise radiation dosing during fluoroscopy. As per the Journal of Digital Imaging, machine learning and artificial intelligence models are increasingly evaluated for automatically detecting anatomical landmarks, showing high positional agreement with manual expert methods. This technological advancement enables manufacturers to offer premium features that differentiate their products in a competitive market. Healthcare providers seek these smart capabilities to improve throughput and patient safety in high-volume surgical centres. The ability to store and analyse procedural data also supports quality improvement initiatives and research. Therefore, the incorporation of AI creates new revenue streams and strengthens the value proposition of modern C-arms by transforming them from passive imaging tools into intelligent surgical assistants.

Expansion into Ambulatory Surgical Centres and Pain Management Clinics

The expansion of ambulatory surgical centres and pain management clinics is driving significant C-arms market growth. This trend offers a substantial opportunity for the deployment of compact and cost-effective C-arm systems. According to reports, surgical procedure volumes are steadily shifting from traditional inpatient hospital settings to ambulatory surgery centres. As per the American Society of Interventional Pain Physicians, millions of epidural steroid injections are performed annually in the US for pain relief, with clinical standards emphasising fluoroscopic guidance for safe needle placement. This growing volume of outpatient procedures creates steady demand for mobile C-arms that are easy to operate and maintain in smaller facilities. Manufacturers can target this segment with specialised models designed for portability and ease of use without compromising image quality. The cost-effectiveness of treating patients in ASCs further encourages investment in essential imaging equipment. Consequently, the rise of outpatient care provides fertile ground for market growth by expanding the user base beyond traditional hospital operating rooms.

MARKET CHALLENGES

Shortage of Skilled Radiologic Technologists and Operators

Many healthcare facilities are currently facing a critical shortage of skilled radiologic technologists and qualified operators, which slows down the growth of the C-arms market. This workforce deficit severely hampers the effective utilisation of advanced C-arm systems. According to studies, severe structural shortages of registered radiologic technologists are expected over the coming decade due to compounding factors like an ageing labour force, institutional burnout, and inadequate clinical training capacities. As per research, many developing nations encounter acute constraints in their specialised clinical imaging workforce, resulting in widespread challenges related to the safe administration of complex diagnostic and interventional radiation modalities. This talent gap forces hospitals to rely on less experienced staff or cross-train nurses who may lack specialised imaging expertise. Inadequate operation can result in poor image quality, repeated exposures, and prolonged procedure times. Training programs are expensive and time-consuming, making it difficult for facilities to quickly address staffing needs. Consequently, the lack of qualified personnel hinders market potential by limiting the safe and efficient deployment of sophisticated C-arm technologies in clinical practice.

Competition from Alternative Imaging Modalities

Alternative imaging modalities, such as intraoperative CT and MRI systems, are creating intense competition in the C-arms market. These alternative technologies present a major obstacle to the traditional dominance of C-arms in complex surgical applications. According to reports, intraoperative CT provides high-resolution three-dimensional stereotactic navigation imaging for specialised spinal and cranial surgeries, leading some centres to adopt it over mobile fluoroscopy systems despite its increased footprint and baseline cost. As per the European Society of Radiology, the adoption of hybrid operating rooms equipped with fixed angiography systems is rising in cardiovascular centres, offering comprehensive imaging capabilities that surpass mobile C-arms in detail and functionality. These advanced alternatives attract high-end customers seeking the highest level of precision for complex cases. While C-arms remain dominant for routine procedures, they face pressure in niche segments where depth perception and soft tissue contrast are critical. The high cost of alternative systems limits their widespread adoption, but they erode the premium segment of the C-arm market. Thus, competition from superior imaging technologies challenges manufacturers to continuously innovate and demonstrate the unique value proposition of fluoroscopy in terms of speed, versatility and cost efficiency.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Device Type Insights

The mobile C-arms segment dominated the global market and accounted for a substantial share in 2025. This dominance was driven by its versatility, portability and ability to serve multiple operating rooms within a single healthcare facility. According to research, mobile imaging units are widely integrated across facilities to enhance flexibility and care delivery. As per sources, mobile fluoroscopic C-arms are frequently deployed during fracture reduction and hardware fixation surgeries to offer real-time anatomical feedback. This dominance is driven by the growing trend toward minimally invasive surgeries, which require compact imaging solutions that do not obstruct the sterile field or limit surgeon movement. Healthcare administrators prefer mobile units because they offer a lower total cost of ownership compared to fixed installations, which require expensive structural modifications and shielding. The ability to share a single mobile unit across orthopaedic pain management and general surgery departments maximises return on investment for budget-constrained institutions. Consequently, mobile C-arms maintain their leadership position by addressing the diverse operational needs of modern hospitals and ambulatory surgical centres where flexibility and cost efficiency are paramount considerations for capital equipment procurement.

The mini C-arms segment is likely to experience the fastest CAGR of 6.8% between 2026 and 2034 due to its specialised application in extremity surgery and point-of-care diagnostics. According to reports, the volume of hand and wrist interventions has grown significantly over time due to demographic shifts and sports injuries. As per studies, tabletop mini C-arms inherently generate smaller radiation dose fields compared to standard, full-sized fluoroscopic platforms. This growth is fueled by the decentralisation of healthcare services as more orthopaedic specialists establish private practices equipped with compact imaging tools for immediate diagnosis and treatment. The smaller footprint of mini C-arms allows them to fit into standard examination rooms without extensive renovation, reducing barriers to entry for private practitioners. Manufacturers are enhancing image quality through digital flat panel detectors specifically designed for extremities, ensuring diagnostic accuracy despite the reduced size. Consequently, the mini C-arm segment expands rapidly as it aligns with the shift toward ambulatory care and the increasing demand for specialised low-dose imaging solutions in non-hospital settings.

By Application Insights

The orthopaedic segment led the C-arms market and captured a significant share in 2025. This prominence was supported by the high volume of joint replacements, fracture repairs, and spinal fusion procedures that rely heavily on fluoroscopic guidance. According to the Global Burden of Disease Study, musculoskeletal disorders rank as the second leading cause of non-fatal disability globally. According to studies, standard diagnostic knee arthroscopies utilise specialised endoscopic cameras for intraoperative visualisation, whereas fluoroscopic C-arm guidance is selectively reserved for specific reconstruction or specialised osseous tracking techniques. This dominance is sustained by the rising prevalence of osteoporosis and trauma cases among elderly populations, which drives consistent demand for orthopaedic surgical services. Surgeons depend on C-arms to minimise incision sizes and ensure proper alignment of prosthetics, which directly impacts patient recovery times and long-term outcomes. The integration of 3D imaging capabilities in modern orthopaedic C-arms further enhances their utility for complex spinal surgeries where precision is critical. Consequently, the orthopaedic segment leads the market by representing the largest user base for fluoroscopic technology, driven by demographic trends and the clinical necessity for accurate skeletal imaging during invasive procedures.

The pain management segment is expected to exhibit a noteworthy CAGR of 7.2% during the forecast period, owing to the opioid crisis and the shift toward interventional non-surgical therapies. The American Academy of Pain Medicine states that over 100 million adults in the United States suffer from chronic pain, leading to a surge in epidural steroid injections, nerve blocks, and radiofrequency ablations that require fluoroscopic guidance for safe needle placement. As per the CDC, non-opioid and interventional therapies are strongly encouraged as foundational components to manage chronic musculoskeletal pain safely. This growth is propelled by the expansion of specialised pain clinics and ambulatory surgical centres that focus exclusively on minimally invasive pain relief procedures. C-arms enable physicians to visualise spinal anatomy in real time, reducing the risk of complications such as dural puncture or vascular injury. Reimbursement policies increasingly favour these outpatient procedures due to their cost-effectiveness compared to major surgery. Consequently, the pain management segment grows rapidly as it addresses a widespread public health issue through targeted image-guided therapies that improve quality of life while minimising systemic medication risks.

REGIONAL ANALYSIS

North America C-Arms Market Analysis

North America was the top performer in the C-arms market and accounted for a substantial share in 2025. This dominance was driven by advanced healthcare infrastructure, high surgical volumes, and strong reimbursement frameworks. According to sources, approximately 50 million surgical procedures occur each year in the United States, driving a robust demand for intraoperative and clinical interventions. As per reports, initiatives such as EuroSAFE Imaging emphasise optimisation and the ALARA principle to manage and minimise patient and staff radiation exposure during fluoroscopic and imaging procedures. The presence of major manufacturers and research institutions fosters rapid adoption of innovative technologies such as 3D fluoroscopy and AI-enhanced imaging. High healthcare expenditure per capita supports the procurement of premium C-arm models with advanced features. The shift toward value-based care encourages facilities to invest in efficient mobile units that can serve multiple specialities. Consequently, North America leads the global market through technological maturity, regulatory rigour, and a high volume of complex surgical interventions that necessitate reliable fluoroscopic support.

Europe C-Arms Market Analysis

Europe was the next most prominent region in the C-arms market in 2025. This position was supported by stringent environmental regulations and a strong focus on radiation dose reduction. According to the European Commission, the implementation of the Medical Device Regulation (MDR) has introduced strict regulatory safety, quality, and clinical performance compliance standards for imaging equipment across Europe. As per research, initiatives such as EuroSAFE Imaging emphasise optimisation and the ALARA principle to manage and minimise patient and staff radiation exposure during fluoroscopic and imaging procedures. The ageing population in countries like Germany and Italy increases the incidence of orthopaedic conditions, sustaining steady demand for surgical imaging. Public healthcare systems prioritise cost-effective mobile solutions that can be shared across departments to optimise resource utilisation. Cross-border collaborations facilitate the adoption of best practices in imaging protocols. Consequently, Europe demonstrates stable growth driven by regulatory compliance, demographic trends, and a commitment to sustainable and safe medical imaging practices.

Asia Pacific C-Arms Market Analysis

The Asia Pacific region is swiftly expanding in the C-arm market because of rapid healthcare infrastructure development and increasing access to surgical care. According to reports, surgical capacity and operating theatre availability continue to expand across developing urban regions to handle higher patient volumes. As per sources, acute injuries arising from traffic accidents and industrial settings require immediate intraoperative imaging to manage fractures effectively. Governments are investing heavily in modernising public hospitals and promoting medical tourism, which drives the procurement of advanced imaging equipment. The availability of cost-effective manufacturing in the region also supports local production of C-arms. Rising middle-class incomes increase demand for high-quality orthopaedic and spinal procedures. Consequently, Asia Pacific exhibits robust growth potential as nations expand their healthcare capabilities and adopt modern surgical technologies to address diverse clinical needs.

Latin America C-Arms Market Analysis

Latin America is an emerging region in the C-arm market owing to gradual modernisation and increasing investment in private healthcare sectors. According to sources, developing national strategies aimed at widening surgical access helps public hospitals secure basic imaging systems. As per studies, the development of outpatient clinics and ambulatory centres across Latin America generates continuous interest in mobile and modular C-arms. The growing prevalence of chronic diseases and ageing populations creates a steady need for orthopaedic and pain management interventions. Economic challenges persist, but international financing and public-private partnerships help facilitate equipment acquisition. Regulatory frameworks are evolving to support device registration and safety standards. Consequently, Latin America shows promising growth as healthcare systems mature and prioritise improving surgical outcomes through better access to intraoperative imaging technologies.

Middle East and Africa C-Arms Market Analysis

The Middle East and Africa region is witnessing growing interest in the C-Arm market due to government initiatives to upgrade healthcare infrastructure and reduce medical tourism outflows. According to studies, economic development programs in Gulf Cooperation Council countries encompass construction projects for hospitals featuring modern operating suites. As per reports, efforts to fortify emergency and trauma infrastructure in sub-Saharan Africa involve expanding the availability of mobile imaging units at referral centres. The rising burden of non-communicable diseases and road traffic injuries necessitates improved diagnostic and surgical capabilities. International collaborations and aid programs support the training of local staff in using imaging equipment safely. Private hospitals in urban centres adopt premium technologies to attract patients seeking high-quality care. Consequently, the Middle East and Africa market is expanding as governments and private entities prioritise modernising surgical infrastructure to meet growing healthcare demands.

COMPETITIVE LANDSCAPE

The competition in the C Arms Market is characterized by intense rivalry among established multinational corporations and emerging regional manufacturers striving for technological superiority. Major players differentiate themselves through continuous innovation in detector technology image processing algorithms and ergonomic design features. Price competitiveness is crucial particularly in price sensitive emerging markets where cost effective solutions are preferred over premium models. Strategic alliances with distributors and local partners help companies navigate complex regulatory landscapes and expand their geographic reach. The shift toward value based care drives demand for equipment that offers lower total cost of ownership including reduced maintenance and energy consumption. Intellectual property protection plays a significant role as firms seek to safeguard their proprietary technologies and maintain competitive advantages. Customer service quality and training programs are key differentiators that influence purchasing decisions in healthcare institutions. Consequently the market landscape remains dynamic with companies constantly adapting to changing clinical requirements and regulatory standards to secure their position.

KEY MARKET PLAYERS

Noteworthy companies in the Global C-Arms Market profiled in the report are 

• GE Healthcare Inc.
• Varian Medical Systems Inc.
• Philips Healthcare
• Siemens AG
• Toshiba Corp
• Hologic Corp
• Omega Medical Imaging Inc.
• BMI Biomedical International
• Hitachi Ltd
• DMS Health Technologies
• ATON GmbH
• Medonica Co. Ltd
• GEMSS Co. Ltd
• Shimadzu Corp

Top Players in the C-Arms Market

Siemens Healthineers

Siemens Healthineers plays a pivotal role by offering advanced mobile and fixed C arm systems equipped with innovative imaging technologies. The company focuses on integrating artificial intelligence into its devices to enhance image quality and reduce radiation exposure for patients and staff. Recent actions include the launch of new flat panel detector models that provide superior clarity for complex orthopedic and vascular procedures. Siemens actively collaborates with hospitals to optimize workflow efficiency through seamless integration with existing digital infrastructure. Their commitment to sustainability drives the development of energy efficient equipment that lowers operational costs. This strategic focus on technological innovation and user centric design strengthens their reputation as a leader in medical imaging. Consequently Siemens maintains a strong market presence by delivering reliable high performance solutions that meet the evolving needs of modern surgical environments.

GE HealthCare

GE HealthCare contributes significantly to the C Arms Market through its comprehensive portfolio of mobile imaging solutions designed for diverse clinical settings. The company emphasizes durability and ease of use ensuring that its devices perform reliably in high volume trauma and surgical centers. Recent initiatives involve expanding service networks in emerging markets to support customers with timely maintenance and technical assistance. GE invests heavily in research and development to introduce lightweight C arms that offer enhanced maneuverability without compromising image resolution. Their partnership with healthcare providers facilitates the adoption of dose management tools that align with strict safety regulations. This approach ensures compliance while improving patient safety standards across global facilities. Consequently GE HealthCare solidifies its position by providing robust versatile imaging systems that empower clinicians to deliver precise and effective care.

Koninklijke Philips N.V.

Koninklijke Philips N.V. leverages its expertise in digital health to deliver smart connected C arm systems that integrate seamlessly with hospital information networks. The company focuses on developing hybrid operating room solutions that combine fluoroscopy with other imaging modalities for comprehensive procedural guidance. Recent actions include enhancing software capabilities to enable real time data sharing and remote collaboration among surgical teams. Philips prioritizes ergonomic design to reduce physical strain on operators during lengthy procedures. Their investment in cloud based analytics helps hospitals track equipment usage and optimize maintenance schedules proactively. This holistic approach improves operational efficiency and extends the lifespan of medical devices. Consequently Philips strengthens its market standing by offering intelligent integrated solutions that support the transition toward value based and data driven healthcare delivery models.

Top Strategies Used by Key Market Participants

Key players in the C Arms Market primarily employ product innovation and strategic partnerships to strengthen their competitive positions. Companies frequently invest in research and development to introduce advanced flat panel detectors and artificial intelligence features that improve image quality and reduce radiation doses. Expanding service networks in emerging markets allows firms to provide better after sales support and build long term customer loyalty. Manufacturers also focus on developing lightweight and compact designs to cater to the growing demand for mobile units in ambulatory surgical centers. Collaborations with healthcare providers facilitate the integration of C arms with digital hospital systems enhancing workflow efficiency. Regulatory compliance remains a priority as companies adapt to stringent safety standards globally. These strategies enable participants to address clinical needs effectively while maintaining operational excellence and driving sustainable growth in a highly specialized medical device sector

RECENT MARKET HAPPENINGS

• In October 2022, the main TIM-3 lung cancer trial by GSK will be launched after the phase 2 hurdle is overcome. After doing well in the study's mid-phase, GSK's anti-TIM-3 antibody is now entering a pivotal trial, solidifying Big Pharma's position as the front-runner in a field that includes Novartis.
• The checkpoint receptor TIM-3 is the most recent target to capture the attention of the immuno-oncology community. Given the failure of Roche's candidate and the waning interest in TIGIT, another checkpoint receptor, TIM-3, could potentially take center stage. However, businesses still need to present data to demonstrate that they can avoid the tragic outcomes of earlier hot immuno-oncology targets.
• In October 2022, late-breaking Phase 3 data on Dupixent® (dupilumab) presented at UEG Week 2022 demonstrated a significant histological remission of eosinophilic esophagitis (EoE) in children aged 1 to 11. In a Phase 3 trial, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi evaluated the practical use of Dupixent® (dupilumab) in children aged 1 to 11 with active eosinophilic esophagitis. Today, the study's late-breaking favorable results were presented (EoE). The information will be disseminated at the United European Gastroenterology Week in 2022 and submitted to regulatory agencies worldwide, beginning with the U.S. Food and Drug Administration (FDA) the following year. As a result, the FDA authorized Dupixent 300 mg once a week in May 2022 for the treatment of EoE in patients 12 years of age and older who weighed at least 40 kg.
• In January 2022, the company stated that physicians will now have access to cutting-edge new 3D image guiding capabilities with Philips Healthcare's Image-Guided Therapy Mobile C-arm System Zenition. The company claimed that the technology would improve endovascular patient outcomes by delivering increased clinical accuracy and efficiency. In addition, to plan and direct surgery in real-time, the business has partnered with Cydar, a U.K.-based cloud-based process maps software provider.
• Patient-specific real-time procedure planning and guiding, optimization of equipment utilization, and usability have become increasingly crucial as patient numbers increase and operations become more complicated and time-consuming. Philips Image-Guided Therapy Mobile C-arm System Zenition combines advances in image capture and processing, usability, and mobility to overcome these difficulties.
• In January 2020, Philips introduced its two new devices to the X-Ray system. Those are named Zenition mobile C-arm platforms and enhancing operating room workflow. Zenition mobile c-arm has a tableside user interface where the technicians can operate efficiently in the sterile field.
• In January 2018, Hologic introduced a new Fluoroscan Insight FD Mini C-Arm where the surgeons, like orthopedists and podiatrists, use these devices. First, the surgeons can adjust the device according to the patient's needs, like high resolution or low dosages. Then, the device controls the system and views the results.
• In September 2011, OrthoScan, Inc. was acquired by ATON GmbH. Orthoscan, Inc. is a prime manufacturer of orthopedic imaging products, including small C-arms. With this acquisition, both companies operate under a joint holding formation that will generate considerable interaction in the upcoming years.

MARKET SEGMENTATION

This research report on the Global C-Arms Market has been segmented and sub-segmented based on the device type, application, and region.

By Device Type

• Mobile C-Arms
• Mini C-Arms
• Full-Size C-Arms
• Fixed C-Arms

By Application

• Orthopedic
• Pain Management and Trauma
• Cardiovascular
• Neurology
• Urology
• Gastrointestinal
• General Surgery

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa